Results 331 to 340 of about 864,255 (364)
Some of the next articles are maybe not open access.
European Journal of Cardiovascular Prevention & Rehabilitation, 1994
Our understanding of the pathophysiological role of lipoprotein (a) in cardiovascular disease and its clinical importance has improved, but there are still gaps in our knowledge and analytical performance that hinder the appropriate management of patients.
openaire +2 more sources
Our understanding of the pathophysiological role of lipoprotein (a) in cardiovascular disease and its clinical importance has improved, but there are still gaps in our knowledge and analytical performance that hinder the appropriate management of patients.
openaire +2 more sources
β-lipoprotein, lipoprotein lipase and atromid
Journal of Atherosclerosis Research, 1963Summary The lipoprotein lipase activity eluted in connection with chromatographically separated β-lipoprotein was considerably lower in 6 cases of essential hyperlipaemia than the average for 7 healthy controls. Atromid administration seemed to increase the lipoprotein lipase activity per mg β-lipoprotein protein in 4 of 5 cases.
P. Bedding, B. Hood, B. Carlander
openaire +3 more sources
Lipoprotein(a) : new insights into an atherogenic lipoprotein
The Clinical Investigator, 1994Lipoprotein(a) constitutes a macromolecular complex in human plasma that combines structural features from the blood clotting and the lipoprotein systems. Aside from the discovery of lipoprotein(a) [Lp(a)] as a potential independent risk factor for premature cardiovascular disease its physiological role and activity remains obscure.
Bartens, Werner, Wanner, Christoph
openaire +3 more sources
The low-density lipoprotein pathway and its relation to atherosclerosis.
Annual Review of Biochemistry, 1977PERSPECTIVES AND SUMMARY 898 LDL, THE MAJOR CHOLESTEROL-CARRYING LIPOPROTEIN OF HUMAN PLASMA . 901 Structure of Plasma LDL .. ... .... 901 Origin of Plasma LDL 902 Catabolism of Plasma LDL 902 THE LDL PATHWAY IN HUMAN FIBROBLASTS ..... ...... 903 The LDL
J. Goldstein, M. Brown
semanticscholar +1 more source
Low-density lipoprotein subclass patterns and risk of myocardial infarction.
Journal of the American Medical Association (JAMA), 1988The association of low-density lipoprotein (LDL) subclass patterns with coronary heart disease was investigated in a case-control study of nonfatal myocardial infarction.
M. Austin +5 more
semanticscholar +1 more source
Lipoprotein(a) and atherogenesis
Trends in Cardiovascular Medicine, 1994Lipoprotein(a) is a major inherited risk factor for atherosclerosis. Many of its activities depend on its plasminlike component, apolipoprotein(a). In vitro studies suggest that apolipoprotein(a) could enhance lipid deposition through binding to sites in the vessel wall, interfere with fibrinolysis, and modulate smooth muscle cell activity.
Richard M. Lawn, Alexander C. Liu
openaire +3 more sources
High-density lipoprotein--the clinical implications of recent studies.
New England Journal of Medicine, 1989DESPITE early observations suggesting an inverse relation between serum levels of high-density lipoprotein (HDL) cholesterol and coronary disease,1 2 3 the possible protective role of HDL in athero...
D. Gordon, B. Rifkind
semanticscholar +1 more source
Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.
Journal of the American Medical Association (JAMA), 2009CONTEXT High levels of lipoprotein(a) are associated with increased risk of myocardial infarction (MI). OBJECTIVE To assess whether genetic data are consistent with this association being causal.
P. Kamstrup +3 more
semanticscholar +1 more source
The Journal of Pediatrics, 1974
D E S P t T E T H E F A C T that hyperlipoproteinemia has received great clinical attention, there is a scarcity of information on the normal distribution of lipids and lipoproteins or screening tests for reliable detection of hyperlipoproteinemia in children.
Hertha R. Cress +3 more
openaire +3 more sources
D E S P t T E T H E F A C T that hyperlipoproteinemia has received great clinical attention, there is a scarcity of information on the normal distribution of lipids and lipoproteins or screening tests for reliable detection of hyperlipoproteinemia in children.
Hertha R. Cress +3 more
openaire +3 more sources
Current Opinion in Lipidology, 2016
Purpose of review Currently, different methods for extracorporeal elimination of atherogenic apolipoprotein B100 containing lipoprotein particles are used in clinical practice. Most of them effectively remove both lipoprotein(a) [Lp(a)] and LDL.
Olga I. Afanasieva +2 more
openaire +2 more sources
Purpose of review Currently, different methods for extracorporeal elimination of atherogenic apolipoprotein B100 containing lipoprotein particles are used in clinical practice. Most of them effectively remove both lipoprotein(a) [Lp(a)] and LDL.
Olga I. Afanasieva +2 more
openaire +2 more sources